Pharmacotherapy of post-traumatic stress disorder

Current Topics in Behavioral Neurosciences

Volumn 2, Issue , 2010, Pages 505-525

  Ravindran, Lakshmi N ^a,b   Stein, Murray B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Biological treatment; Medication; Pharmacotherapy; Post traumatic stress disorder; PTSD; Treatment

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CITALOPRAM; CLONAZEPAM; DESIPRAMINE; FLUOXETINE; HYPNOTIC AGENT; IMIPRAMINE; LAMOTRIGINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PHENELZINE; PLACEBO; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADJUVANT THERAPY; ANTIADRENERGIC EFFECT; ANTICHOLINERGIC EFFECT; DRUG ACTIVITY; DRUG APPROVAL; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME INHIBITION; HUMAN; LIVER TOXICITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SLEEP DISORDER; SLEEP QUALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ADRENERGIC ANTAGONISTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; MONOAMINE OXIDASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 79952261281     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2009_15     Document Type: Review

References (94)

1. Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ (2004) Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 161:1488-1490
2. Bahk WM, Pae CU, Tsoh J, Chae JH, Jun TY, Chul L, Kim KS (2002) Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study. Hum Psychopharmacol 17:341-344
3. Baker DG, Diamond BI, Gillette G, Hamner M, Katzelnick D, Keller T, Mellman TA, Pontius E, Rosenthal M, Tucker P (1995) A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl) 122:386-389
4. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J, Hollander E, Kasper S, Moller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lepine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision. World J Biol Psychiatry 9:248-312
5. Bartzokis G, Lu PH, Turner J, Mintz J, Saunders CS (2005) Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry 57: 474-479
6. Battista MA, Hierholzer R, Khouzam HR, Barlow A, O'Toole S (2007) Pilot trial of memantine in the treatment of posttraumatic stress disorder. Psychiatry 70:167-174
7. Becker ME, Hertzberg MA, Moore SD, Dennis MF, Bukenya DS, Beckham JC (2007) A placebocontrolled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol 27:193-197
8. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000) Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 283:1837-1844
9. Braun P, Greenberg D, Dasberg H, Lerer B (1990) Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 51:236-238
10. Buchanan TW, Tranel D, Adolphs R (2006) Impaired memory retrieval correlates with individual differences in cortisol response but not autonomic response. Learn Mem 13:382-387
11. Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR (2001) Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 16:197-203
12. Cahill L, Prins B, Weber M, McGaugh JL (1994) Beta-adrenergic activation and memory for emotional events. Nature 371:702-704
13. Cates ME, Bishop MH, Davis LL, Lowe JS, Woolley TW (2004) Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother 38:1395-1399
14. Clark RD, Canive JM, Calais LA, Qualls C, Brugger RD, Vosburgh TB (1999) Cyproheptadine treatment of nightmares associated with posttraumatic stress disorder. J Clin Psychopharmacol 19:486-487
15. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR (1999) Fluoxetine in posttraumatic stress disorder. Randomised, double-blind study. Br J Psychiatry 175:17-22
16. Connor KM, Davidson JR, Weisler RH, Zhang W, Abraham K (2006) Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl) 184:21-25
17. Copeland WE, Keeler G, Angold A, Costello EJ (2007) Traumatic events and posttraumatic stress in childhood. Arch Gen Psychiatry 64:577-584
18. Chung MY, Min KH, Jun YJ, Kim SS, Kim WC, Jun EM (2004) Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol 19:489-94
19. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, Saunders WB, Cavenar JO Jr (1990) Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 47:259-266
20. Davidson JR, Weisler RH, Malik M, Tupler LA (1998) Fluvoxamine in civilians with posttraumatic stress disorder. J Clin Psychopharmacol 18:93-95
21. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001a) Multicenter, doubleblind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58:485-492
22. Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G (2001b) Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974-1981
23. Davidson JR, Weisler RH, Butterfield MI, Casat CD, Connor KM, Barnett S, van Meter S (2003) Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry 53:188-191
24. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ (2006a) Venlafaxine extended release in posttraumatic stress disorder: a sertraline-and placebo-controlled study. J Clin Psychopharmacol 26:259-267
25. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J (2006b) Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry 63:1158-1165
26. Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH (2007) The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol 27:85-88
27. Davis R, Whittington R, Bryson HM (1997) Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 53:608-636
28. Davis LL, Jewell ME, Ambrose S, Farley J, English B, Bartolucci A, Petty F (2004) A placebocontrolled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol 24:291-297
29. Davis LL, Davidson JR, Ward LC, Bartolucci A, Bowden CL, Petty F (2008a) Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol 28:84-88
30. Davis LL, Ward C, Rasmusson A, Newell JM, Frazier E, Southwick SM (2008b) A placebocontrolled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull 41:8-18
31. de Jong JT, Komproe IH, Van Ommeren M, El Masri M, Araya M, Khaled N, van De PW, Somasundaram D (2001) Lifetime events and posttraumatic stress disorder in 4 postconflict settings. JAMA 286:555-562
32. Drake RG, Davis LL, Cates ME, Jewell ME, Ambrose SM, Lowe JS (2003) Baclofen treatment for chronic posttraumatic stress disorder. Ann Pharmacother 37:1177-1181
33. English BA, Jewell M, Jewell G, Ambrose S, Davis LL (2006) Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial. J Clin Psychopharmacol 26:84-88
34. Escalona R, Canive JM, Calais LA, Davidson JR (2002) Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. Depress Anxiety 15:29-33
35. Foa EB, Davidson JR, Frances A (1999) The expert consensus guidelines series: treatment of posttraumatic stress disorder. J Clin Psychiatry 60(Suppl 16):3-76
36. Foa EB, Keane TM, Friedman MJ (2000) Guidelines for treatment of PTSD. J Trauma Stress 13:539-588
37. Frank JB, Kosten TR, Giller EL Jr, Dan E (1988) A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 145:1289-1291
38. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM (2007) Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 68:711-720
39. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY (1996) Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 57:390-394
40. Hamner MB, Faldowski RA, Ulmer HG, Frueh BC, Huber MG, Arana GW (2003) Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 18:1-8
41. Heresco-Levy U, Kremer I, Javitt DC, Goichman R, Reshef A, Blanaru M, Cohen T (2002) Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol 5:301-307
42. Hertzberg MA, Butterfield MI, Feldman ME, Beckham JC, Sutherland SM, Connor KM, Davidson JR (1999) A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45:1226-1229
43. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR (2000) Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 12:101-105
44. Hertzberg MA, Moore SD, Feldman ME, Beckham JC (2001) A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol 21:94-98
45. Katz RJ, Lott MH, Arbus P, Crocq L, Herlobsen P, Lingjaerde O, Lopez G, Loughrey GC, MacFarlane DJ, McIvor R (1994) Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety 1:169-174
46. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602
47. Kim W, Pae CU, Chae JH, Jun TY, Bahk WM (2005) The effectiveness of mirtazapine in the treatment of post-traumatic stress disorder: a 24-week continuation therapy. Psychiatry Clin Neurosci 59:743-747
48. Kindt M, Soeter M, Vervliet B (2009) Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci. doi:10.1038/nn.2271
49. Kinzie JD, Leung P (1989) Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 177:546-550
50. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr (1991) Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179:366-370
51. Lindley SE, Carlson EB, Hill K (2007) A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol 27:677-681
52. Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM (2001) Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Clin Psychiatry 62:325-331
53. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R, Smiga S, Tecott L, Neylan T (1996) Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 57(Suppl 8):66-70
54. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001) Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 158:1982-1988
55. Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR (2007) A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety 24:77-84
56. Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC (2002a) Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry 63:199-206
57. Martenyi F, Brown EB, Zhang H, Koke SC, Prakash A (2002b) Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry 181:315-320
58. Martenyi F, Brown EB, Caldwell CD (2007) Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol 27:166-170
59. McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W (2004) Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety 19:190-196
60. Mellman TA, Bustamante V, David D, Fins AI (2002) Hypnotic medication in the aftermath of trauma. J Clin Psychiatry 63:1183-1184
61. Milliken CS, Auchterlonie JL, Hoge CW (2007) Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war. JAMA 298:2141-2148
62. Mohamed S, Rosenheck RA (2008) Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic-and symptom-guided drug selection. J Clin Psychiatry 69:959-965
63. Monnelly EP, Ciraulo DA, Knapp C, Keane T (2003) Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 23:193-196
64. Nair J, Singh AS (2008) The role of the glutamatergic system in posttraumatic stress disorder. CNS Spectr 13:585-591
65. Neylan TC, Lenoci M, Samuelson KW, Metzler TJ, Henn-Haase C, Hierholzer RW, Lindley SE, Otte C, Schoenfeld FB, Yesavage JA, Marmar CR (2006) No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry 163:2186-2188
66. Onder E, Tural U, Aker T (2006) A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry 21:174-179
67. Padala PR, Madison J, Monnahan M, Marcil W, Price P, Ramaswamy S, Din AU, Wilson DR, Petty F (2006) Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol 21:275-280
68. Pitman RK (1989) Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 26:221-3
69. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, Cahill L, Orr SP (2002) Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51:189-192
70. Post RM, Weiss SR, Smith M, Li H, McCann U (1997) Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder. Ann N Y Acad Sci 821:285-295
71. Rapaport MH, Endicott J, Clary CM (2002) Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry 63:59-65
72. Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, Dobie DJ, Hoff D, Rein RJ, Straits-Troster K, Thomas RG, McFall MM(2003) Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 160:371-373
73. Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, Shofer J, O'Connell J, Taylor F, Gross C, Rohde K, McFall ME (2007) A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 61:928-934
74. Reich DB, Winternitz S, Hennen J, Watts T, Stanculescu C (2004) A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry 65:1601-1606
75. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, Nelson JN (1989) A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 146:513-516
76. Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL (2006) Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. J Clin Psychiatry 67:1522-1526
77. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL (2006) Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 103:6741-6746
78. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH (2008) Placebocontrolled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry 69:520-525
79. Rush AJ (2007) STAR*D: what have we learned? Am J Psychiatry 164:201-204
80. Sageman S, Brown RP (2006) 3-acetyl-7-oxo-dehydroepiandrosterone for healing treatmentresistant posttraumatic stress disorder in women: 5 case reports. J Clin Psychiatry 67:493-496
81. Sargant W, Slater E (1940) Acute war neuroses. Lancet 236:1-2
82. Seedat S, Stein DJ, Ziervogel C, Middleton T, Kaminer D, Emsley RA, Rossouw W (2002) Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 12:37-46
83. Shestatzky M, Greenberg D, Lerer B (1988) A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 24:149-155
84. Stahl SM (1998) Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215-235
85. Stein DJ, Bandelow B, Hollander E, Nutt DJ, Okasha A, Pollack MH, Swinson RP, Zohar J (2003) WCA Recommendations for the long-term treatment of posttraumatic stress disorder. CNS Spectr 8:31-39
86. Stein MB, Kline NA, Matloff JL (2002) Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 159:1777-1779
87. Stein MB, Kerridge C, Dimsdale JE, Hoyt DB (2007) Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress 20:923-932
88. Taylor FB, Martin P, Thompson C, Williams J, Mellman TA, Gross C, Peskind ER, Raskind MA (2008) Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 63:629-632
89. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD (2001) Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexibledosage trial. J Clin Psychiatry 62:860-868
90. Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu SC, Capece JA, Rosenthal NR (2007) Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68:201-206
91. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos RS, Zatzick DF, Benedek DM (2004) American Psychiatric Association Practice Guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. American Psychiatric, Arlington, VA, pp 1-96
92. Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, Marmar CR (2003) Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 54:947-949
93. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994) Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55:517-522
94. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C (2002) Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 22:190-195